It has been suggested that LMR has prognostic value in advanced lung cancer patients who received platinum-based chemotherapies [36] and in advanced-stage EGFR-mutant NSCLC receiving EGFR-TKIs [37]. The gene discussed is EGFR; the disease is lung carcinoma.